Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ROCK
    (3)
  • Adrenergic Receptor
    (2)
  • Neuropeptide W
    (2)
  • Monoamine Transporter
    (1)
  • P-gp
    (1)
  • Potassium Channel
    (1)
  • Prostaglandin Receptor
    (1)
  • Wnt/beta-catenin
    (1)
  • Others
    (7)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (3)
  • Nervous System
    (2)
  • Cancer
    (1)
Filter
Search Result
Results for "

outflow

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    14
    TargetMol | All_Pathways
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
BAY 73-1449
BAY73-1449, BAY-73-1449
T26745693790-96-4
BAY 73-1449 is a potent and selective antagonist of the prostacyclin receptor (IC50 < 0.1 nM).
  • $37
In Stock
Size
QTY
Verosudil
AR-12286
T609241414854-42-4
Verosudil (AR-12286) is a highly potent Rho kinase (ROCK) inhibitor with a Ki of 2 nM and 2 nM against ROCK1 and ROCK2, respectively. AR-12286 mitigates steroid-induced intraocular pressure in mice by decreasing intraocular pressure through enhanced outflow of aqueous humor via the trabecular meshwork.
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Sale
17-Phenyl trinor 8-iso prostaglandin E2
T211523
17-Phenyl trinor 8-iso prostaglandin E2 is a prostaglandin analog that reduces intraocular pressure (IOP) in both normal and glaucomatous monkey eyes. It primarily lowers IOP by enhancing trabecular outflow facility.
  • Inquiry Price
Inquiry
Size
QTY
SB772077B
T213810785774-34-7
SB772077B is a ROCK inhibitor with anti-inflammatory properties. It boosts aqueous humor outflow (OF) by inhibiting the RhoA/ROCK signaling pathway. This compound significantly reduces mRNA levels of β-catenin and protein levels of fibrosis markers such as vinculin, fibronectin, collagen1 A, and vimentin. Additionally, SB772077B exhibits vasodilatory effects, lowering both pulmonary arterial and systemic blood pressure. It is useful for research on glaucoma and pulmonary arterial hypertension.
  • Inquiry Price
10-14 weeks
Size
QTY
(S)-Doxazosin
(S)-UK 33274
T214249104874-86-4
(S)-Doxazosin is a long-acting selective α1-adrenergic receptor antagonist. By selectively blocking postsynaptic α1 receptors, it reduces total peripheral resistance, thereby exerting an antihypertensive effect. (S)-Doxazosin lowers blood pressure in canine models of experimentally induced renal hypertension and alleviates bladder outflow obstruction. It is also applicable in research related to psychiatric disorders.
  • Inquiry Price
10-14 weeks
Size
QTY
Trazium Esilate
EGYT-3615, EGYT3615, EGYT 3615
T2900297110-59-3
Trazium esilate is an adrenergic receptor antagonist. Trazium esilate is a weak displacer on a1-, a2- and D2-receptors, however, it induced a2-receptor desenzitization after repeated treatment. It had no influence on rat brain cortical noradrenaline and s
  • $1,520
6-8 weeks
Size
QTY
δ14-Triamcinolone acetonide
T354611260149-96-9
δ14-Triamcinolone acetonide is a potential impurity found in commercial preparations of triamcinolone acetonide. Triamcinolone acetonide is a synthetic corticosteroid. It decreases cytokine levels, the firing rate of sensory neurons, and mechanical hypersensitivity in a rat spinal nerve ligation model when used at a dose of 1.5 mg/kg prior to and following surgery for three days. Triamcinolone acetonide also decreases outflow facility in a mouse model of steroid-induced glaucoma when 20 μl of a 40 mg/ml suspension is administered subconjunctivally. Formulations containing triamcinolone acetonide are used in the treatment of diabetic macular edema.
  • $366
35 days
Size
QTY
(E)-Guanabenz
T6030460329-03-5
(E)-Guanabenz ((E)-Wy-8678), an oral central α2-adrenoceptor agonist, exhibits antihypertensive and neuroprotective activities by stimulating central α2-adrenoceptors to reduce sympathetic outflow and directly inhibiting GADD34. It is used in researching hypertension and Parkinson's disease [1] [2].
  • $2,140
6-8 weeks
Size
QTY
Netarsudil free base
T711191254032-66-0
Netarsudil, also known as AR-11324, is a Rho-associated protein kinase inhibitor. Netarsudil is potential useful for treating glaucoma and/or reducing intraocular pressure. Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms. Netarsudil inhibited kinases ROCK1 and ROCK2 with a Ki of 1 nM each, disrupted actin stress fibers and focal adhesions in TM cells with IC50s of 79 and 16 nM, respectively, and blocked the profibrotic effects of TGF-β2 in HTM cells. Netarsudil produced large reductions in IOP in rabbits and monkeys that were sustained for at least 24 h after once daily dosing, with transient, mild hyperemia observed as the only adverse effect.
  • $2,120
1-2 weeks
Size
QTY
Nicorandil-D4
T714021132681-23-2
Nicorandil-D4 is intended for use as an internal standard for the quantification of nicorandil by GC- or LC-MS. Nicorandil (T0075) is an activator of sulfonylurea receptor 2B (SUR2B) linked to ATP-sensitive potassium channel Kir6.2 (EC50 = ~10 µM) and a nitric oxide (NO) donor. It is selective for SUR2B/Kir6.2 over the SUR2A/Kir6.2 channel (EC50 = >500 µM). Nicorandil (T0075) activates soluble guanylate cyclase in a cell-free assay and relaxes partially depolarized isolated bovine coronary artery strips (EC50 = 4.4 µM). It decreases mean blood pressure, coronary resistance, and heart rate, as well as increases coronary sinus outflow, in dogs when administered intravenously at a dose of 1 mg/kg. Nicorandil (T0075) increases survival and decreases infarct size in a rabbit model of myocardial ischemia-reperfusion injury induced by left coronary artery occlusion. Formulations containing nicorandil have been used in the treatment of angina pectoris.
  • $223
35 days
Size
QTY
P-gb-IN-1
T775752632874-49-6
P-gb-IN-1 is a potent P-glycoprotein (P-gp) inhibitor that exhibits reverse activity by inhibiting P-gp outflow. P-gb-IN-1 has been shown to inhibit P-gp by hydrogen bonding with residues Asn 721 and Met 986. P-gb-IN-1 showed low toxicity in MCF-7/ADR cells.
  • $82
In Stock
Size
QTY
Neuropeptide W-30 (human)
NPW30, human
TP2610383415-80-3
Neuropeptide W-30 (human) serves as a crucial stress mediator within the central nervous system, influencing the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. It acts as an endogenous ligand for the two related orphan G-protein-coupled receptors (GPCRs), GPR7 and GPR8, binding and activating them at comparable effective doses [1] [2] [3].
  • Inquiry Price
Inquiry
Size
QTY
Neuropeptide W-30 (rat)
NPW30, rat
TP2611383415-90-5
Neuropeptide W-30 (rat) acts as a crucial stress mediator within the central nervous system, influencing the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. It serves as an endogenous ligand for the two related orphan G-protein-coupled receptors (GPCRs), GPR7 and GPR8. NPW-30 binds and activates both GPR7 and GPR8 at comparable effective doses [1] [2] [3].
  • Inquiry Price
Inquiry
Size
QTY
8-Iso-17-phenyl trinor prostaglandin F2β
8-Iso-17-phenyl PGF2β
TYD-03538
8-Iso-17-phenyl trinor prostaglandin F2β is an isomer of Bimatoprost. Bimatoprost, a prostaglandin analog, works by reducing intraocular pressure through the regulation of uveoscleral and trabecular outflow.
  • Inquiry Price
Inquiry
Size
QTY